Laleh Eslamian
Tehran, 14114, Iran
NCT Number: NCT01085006
Intravenous Tranexamic acid is used to reduce the hemorrhage during and after cesarean delivery in a double blind randomized placebo controlled trial.
Looking for future studies?
Notify MeFemale
Interventional
Phase 1 / Phase 2
Tehran, 14114, Iran
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tranexamic acid in cases, normal saline in controls
Tranexamic acid in cases, normal saline in controls
Time frame: During the procedure and within 2 hours afterwards
Time frame: First 24 hours
Tehran University of Medical Sciences
Other
The Effect of Tranexamic Acid Administration on Postpartum Hemorrhage During and After Cesarean Delivery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04186416
Fluid Responsiveness, Hemorrhage
Paris, France
View Trial DetailsNCT03364491
Hemorrhage, Labor and Delivery
Birmingham, Alabama, United States
View Trial DetailsNCT06170619
Bleeding, Hemorrhage
Phoenix, Arizona, United States
View Trial DetailsNCT02797119
Female Urogenital Diseases and Pregnancy Complications, Hemorrhage
Lille, France
View Trial Details